Despite decades of vancomycin use, few reports of clinically significant vancomycin resistance among isolates of gram-positive bacteria have appeared in the literature. Recently, isolates of vancomycin-resistant coagulase-negative staphylococci (17) and enterococci (19) have been described. Vancomycin resistance has been reported in clinical isolates of Leuconostoc and Pediococcus, genera of "lactic acid bacteria" that resemble streptococci morphologically (3, 5, 6, 9, 15) . Although vancomycin resistance has been reported in a strain of viridans group streptococcus (18), this isolate most likely represents a case of a lactobacillus mistaken for a streptococcus (C. Thornsberry and R. Facklam, Antimicrob. Newsl. 1:63-64, 1984). These reports emphasize the resemblance of certain lactic acid bacteria to streptococci and the difficulties in correctly identifying vancomycinresistant gram-positive organisms.
Despite decades of vancomycin use, few reports of clinically significant vancomycin resistance among isolates of gram-positive bacteria have appeared in the literature. Recently, isolates of vancomycin-resistant coagulase-negative staphylococci (17) and enterococci (19) have been described. Vancomycin resistance has been reported in clinical isolates of Leuconostoc and Pediococcus, genera of "lactic acid bacteria" that resemble streptococci morphologically (3, 5, 6, 9, 15) . Although vancomycin resistance has been reported in a strain of viridans group streptococcus (18) , this isolate most likely represents a case of a lactobacillus mistaken for a streptococcus (C. Thornsberry and R. Facklam, Antimicrob. Newsl. 1:63-64, 1984) . These reports emphasize the resemblance of certain lactic acid bacteria to streptococci and the difficulties in correctly identifying vancomycinresistant gram-positive organisms.
We examined 36 isolates of vancomycin-resistant grampositive bacteria recovered from specimens submitted to the clinical bacteriology laboratory to study their morphological and physiological characteristics and to assess their clinical significance.
MATERIALS AND METHODS Bacterial strains and cultivation media. Isolates were routinely cultured on plates containing brucella agar supplemented with 5% horse blood (GIBCO Diagnostics, Madison, Wis.). Cultures were incubated at 35°C in an atmosphere containing 5% C02. Long-term storage of organisms was accomplished by freezing suspensions of the bacteria in horse blood. Stock strains used in these studies were obtained from the American Type Culture Collection (ATCC), Rockville, Md., and included Leuconostoc Aerococcus sp. from The Massachusetts General Hospital Bacteriology Laboratory culture collection was also used in some studies.
Isolation of vancomycin-resistant strains from stool specimens. Portions of approximately 100 stool specimens submitted to the laboratory for culturing of enteric pathogens were streaked onto plates containing Thayer-Martin medium (GIBCO). After overnight incubation at 35°C in the presence of air containing 5% CO2, colonies were picked, restreaked on brucella agar containing 5% horse blood, and checked for purity.
Vancomycin susceptibility tests. All isolates were tested for vancomycin susceptibility with 30-,ug disks (Organon Teknika, Irving, Tex.) by the disk diffusion method (12) with certain modifications. Inocula were grown in lactobacilli MRS broth (Difco Laboratories, Detroit, Mich.) and streaked onto blood-supplemented Mueller-Hinton agar plates (GIBCO). Plates were incubated at 35°C in increased (5%) C02. All isolates were tested for their ability to grow in MRS broth containing 256 ,ug of vancomycin (Sigma Chemical Co., St. Louis, Mo.) per ml according to National Committee for Clinical Laboratory Standards methodology (13) .
Bacteriological studies. The ability of the isolates to produce gas from glucose was tested by growth at 35°C in MRS broth overlaid with petrolatum. Cellular morphology was determined from Gram stains of cells grown on horse blood agar plates, in thioglycolate broth (GIBCO), and in MRS broth sealed with petrolatum. Cells for the assay of catalase production, tested by hydrogen peroxide decomposition, were grown on horse blood agar medium. Catalase-positive isolates were subcultured on brucella agar slants (GIBCO) and retested for catalase production. All isolates with positive catalase reactions on blood agar or on both blood agar and brucella agar were tested by the method of Wong (21) for the production of porphobilinogen and porphyrin from 8- aminolevulinic acid. Stock strains of Micrococcus luteus and Enterococcus faecalis were used, respectively, as positive and negative controls. All strains were tested for polysaccharide production by observation of growth on heart infusion agar (Difco) containing 5% sucrose. Cultures on solid All of the vancomycin-resistant strains studied were grampositive bacteria which displayed definite rodlike, coccoid, or indeterminate (questionable short rods or coccobacilli) cell morphology. Of the 36 isolates, 8 were able to decompose hydrogen peroxide when grown on blood agar; 5 of these also produced positive reactions with hydrogen peroxide when grown on a medium (brucella agar) devoid of blood. All eight peroxide-decomposing strains produced negative results for porphobilinogen and porphyrin synthesis when tested by the method of Wong (21) . Some basic characteristics of the 36 isolates are summarized in Table 1 .
Twenty-three of the isolates failed to produce gas from glucose when grown in MRS broth overlaid with petrolatum. Twenty of these displayed rodlike morphology in Gramstained smears and were tentatively identified as lactobacilli. Some strains had coccoid cells, usually when grown on blood agar, but rod-shaped cells were observed in Gram stains of broth cultures.
The remaining three strains that failed to produce gas from glucose formed coccoid cells arranged in tetrads and pairs. Two of these strains produced positive catalase reactions but were negative in tests for porphyrin and porphobilinogen. The isolates grew well on blood agar plates incubated Of the 13 isolates capable of gas production from glucose, 11 were tentatively identified as lactobacilli or leuconostocs on the basis of cellular morphology. The remaining two isolates showed indeterminate morphology, with cells resembling either very short rods or coccobacilli, and thus, on the basis of morphology, could not be placed in either genus.
Reactions of the heterofermentative isolates on API Rapid Strep strips were variable, except for the reactions noted in Table 2 . Four of the five rod-shaped bacterial strains, tentatively identified as lactobacilli, hydrolyzed arginine and produced leucine arylamidase. The remaining strain with rod-shaped cells was exceedingly unreactive and produced a positive reaction on the API strip only in the Voges-Proskauer test. The six isolates with definite coccoid morphology were all negative in the arginine hydrolysis and leucine arylamidase tests and were tentatively identified as Leuconostoc strains. Some of these strains formed polysaccharides when grown on a sucrose-containing medium, a characteristic of Leuconostoc mesenteroides subsp. mesenteroides and Leuconostoc mesenteroides subsp. dextranicum (7) .
The remaining two heterofermentative isolates showed neither clearly rod-shaped nor coccoid morphology in stains of cells from any growth medium and thus, on the basis of morphology, are referred to here as "indeterminate" with respect to genus affiliation. These isolates resembled the Leuconostoc strains in their arginine hydrolysis and leucine arylamidase reactions and ability to produce polysaccharide ( Table 2) .
The possibility that resistant strains were able to destroy or inactivate vancomycin was explored with ATCC strains of Lactobacillus plantarum, P. acidilactici, and P. pentosaceus, the three stool isolates of pediococci, and five clinical isolates (two strains of lactobacilli, two strains of leuconostocs, and one strain of questionable identity). Inhibition zones of 17 mm were noted against S. aureus with disks seeded with uninoculated broth containing 1,000 ,ug of vancomycin per ml and with spent vancomycin-supplemented broth from 10 of the 11 isolates tested. Spent broth from the remaining isolate tested produced inhibition zones of 16 mm against the test organism. S. aureus was not inhibited by spent broth from vancomycin-free cultures of the 11 strains.
Clinical correlation. The charts of 10 patients from whom vancomycin-resistant gram-positive organisms were isolated were available for review (Table 3 ). In three patients the vancomycin-resistant organism was identified as a Leuconostoc sp.; in five patients the vancomycin-resistant organism was identified as a Lactobacillus sp. In two patients the isolates could not be assigned unambiguously to either genus.
In four patients, isolates were recovered from normally sterile body sites (patients 1 to 4, Table 3 ). In two cases (patients 1 and 2), the isolates were considered probably clinically significant. In two other cases (patients 3 and 4), the isolates were considered possibly significant, but specific findings precluded the assignment of a pathogenic role to the vancomycin-resistant organisms.
Six patients (patients 5 to 10, In addition to homofermentative lactobacilli, we also recovered three vancomycin-resistant strains of non-gasproducing bacteria which appeared to be members of the genus Pediococcus. Two additional Pediococcus strains obtained from the ATCC were also vancomycin resistant.
Pediococci, usually isolated from vegetable material, may be confused with aerococci or even micrococci, owing to their cellular morphology (gram-positive cocci in tetrads) and the positive catalase reactions of some strains. Pediococci, unlike micrococci, do not synthesize cytochromes and may be differentiated from both aerococci and micrococci by their ability to grow luxuriantly under anaerobic conditions (8) . Additionally, 24 Aerococcus strains examined by Swenson and co-workers were found to be vancomycin susceptible (J. M. Swenson, G. S. Bosley, R. R. Facklam, and C. Thornsberry, Program Abstr. 27th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 786, 1987). Whereas pediococci have been recovered from feces (1) , as our three isolates were, to our knowledge there is only one report describing the isolation of pediococci from clinical specimens (5) . However, pediococci, like leuconostocs before the first report of their clinical significance (3), may simply be unrecognized when encountered in clinical laboratories.
Previous reports have stressed gas production from glucose as an important identifying feature of leuconostocs.
While this characteristic will separate leuconostocs from streptococci and homofermentative lactobacilli, it is of no use for differentiation between leuconostocs and heterofermentative lactobacilli. These two groups of organisms may have very similar morphology, as discussed by Garvie (7) and as observed with our two isolates of indeterminate genus affiliation. Nucleic acid homology studies are needed to clarify the taxonomic divisions among these closely related bacteria.
The data in Table 2 suggest that arginine hydrolysis and leucine arylamidase reactions may be useful for distinguishing leuconostocs and heterofermentative lactobacilli, but lactobacilli may be arginine hydrolysis negative (7, 11) . We also noted that the ATCC strain of Leuconostoc paramesenteroides produced a consistently positive leucine arylamidase reaction in our experiments. Colman and Ball (4) , using the API 20 Strep kit, reported that three of four Leuconostoc strains they examined were leucine arylamidase positive.
Bridge and Sneath (2) reported that six leuconostoc strains hydrolyzed gelatin, a characteristic not found among the lactobacilli (11) . This trait could be an easily determined characteristic for Leuconostoc-Lactobacillus differentiation. However, we observed negative reactions for gelatin hydrolysis with all ATCC and other Leuconostoc strains tested on nutrient gelatin medium and in thioglycolate broths containing either 5 or 2% gelatin after incubation at 35°C for 14 days. have presented data on a limited number of strains which suggest that enzymatic profiles may aid in the differentiation of Leuconostoc and Lactobacillus species. The lack of reliable differential tests for leuconostocs and heterofermentative lactobacilli at the present time forces workers in clinical laboratories to rely on morphology for identification, but as mentioned previously, morphological determinations may be inconclusive.
We did not recover any vancomycin-resistant staphylococci or enterococci. Reports of resistance in these organisms are rare (17, 19) , and it has been suggested that resistant isolates arise in response to long-term vancomycin treatment of their hosts. In contrast, vancomycin resistance in lactobacilli, leuconostocs, and pediococci appears to be a natural phenomenon.
All of the vancomycin-resistant isolates studied were able to grow in high concentrations of the drug, as has been reported previously for members of the genera Leuconostoc (3, 6, 9, 14, 15) and Lactobacillus (20) . The Leuconostoc isolates examined by others (10, 14) and the Leuconostoc, Lactobacillus, and Pediococcus strains tested here failed to inactivate vancomycin when tested in a bioassay, suggesting that these organisms form cell walls whose synthesis is unaffected by the antibiotic.
Eight patients with clinically significant isolates of Leuconostoc spp. have been reported (3, 6, 8a, 9, 15). All but one of these patients had an underlying medical condition, such as prior surgery (15) , intravenous catheter (9, 15) , or steroid therapy (15) , that predisposed them to infection. The only previous report of Leuconostoc spp. causing infection in a normal host was that of a 16-year-old girl with purulent meningitis (6) .
In four of the patients reported here the isolation of vancomycin-resistant gram-positive organisms was thought to have probable (patients 1 and 2) or possible (patients 3 and 4) clinical significance. The common occurrence of coinfecting organisms in these patients may reflect the severity of their underlying disease (as in patient 4) or the site of isolation (as in patients 1 and 2). Patients 1, 3, and 4 had multisystem diseases which required prolonged hospitalization and numerous courses of antibiotics. By contrast, patient 2 was a previously healthy man whose only predisposing medical problem was diverticulosis. Leuconostocs and vancomycin-resistant lactobacilli may therefore represent a newly recognized group of nosocomial pathogens.
Although five of our patients had been treated with vancomycin prior to the isolation of the organisms (patients 4, 5, 6, 7, and 10), four patients had not (patients 1, 2, 8, and 9).
The antibiotic exposure of patient 3 could not be established.
The absence of a suitably matched control group of patients from whom vancomycin-resistant organisms were not recovered prevents us from correlating vancomycin usage with the emergence of these organisms.
Of our 10 isolates, 6 came from sites contiguous with the gastrointestinal tract. A previous report (15) 
